Results 221 to 230 of about 179,076 (300)
We found the estimated use of tiger bone glue within the last 12 months to be 6.9%. We found a stated motivation of taking TBG to improve health, and by the suggestion of one's social group. We suggest reducing the acceptability of TBG as medicine and encouraging non‐animal‐based medicinal alternatives.
Elizabeth Oneita Davis +5 more
wiley +1 more source
Editorial: Women in science: musculoskeletal pain. [PDF]
Shannonhouse J, Kim YS.
europepmc +1 more source
ABSTRACT Background Temporomandibular disorders (TMDs) and orofacial pain (OFP) demand advanced diagnostic and clinical reasoning skills in dental education. Traditional simulations with real patients face limitations in availability and standardization.
Paula Rodrigues‐Pereira +7 more
wiley +1 more source
Prevalence and Predictors of Musculoskeletal Pain Among Pregnant Women: A Cross-Sectional Study. [PDF]
Uddin J, Shumi SS, Flatt JD.
europepmc +1 more source
ABSTRACT Objectives Dentists are at risk of developing musculoskeletal pain (MP) during their professional lives. The objectives were to compare dental students’ and dentists’ professional pain–related education, current professional pain, coping strategies, and evaluations of ways to alleviate pain.
Shraddha Ramnath, Marita R. Inglehart
wiley +1 more source
Musculoskeletal Orofacial Pain
Sujay A. J. Mehta
doaj +1 more source
Virtual reality for the management of musculoskeletal pain: an umbrella review. [PDF]
Kalikanov S +3 more
europepmc +1 more source
Things We Do for No Reason™: Prescribing gabapentinoids for pain
Abstract Gabapentin and pregabalin are among the most frequently prescribed medications in the United States, with gabapentin in the top 10 and pregabalin in the top 100. Despite FDA approval for only select neuropathic conditions, most use is for off‐label pain indications.
Niti G. Patel +4 more
wiley +1 more source
Looking Inwards: The Role of Self-Care, Self-Management and Self-Healing in Musculoskeletal Pain. [PDF]
McSwan J, Panwar CE, Mobasheri A.
europepmc +1 more source

